Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. APGE
5. USO
6. GOOGL
7. MU
8. HOOD
9. DFTX
10. RGNX

Go back to Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results

Vir Biotechnology Inc. (VIR) Misses Q4 EPS by 41c

February 23, 2023 4:27 PM EST

Vir Biotechnology Inc. (NASDAQ: VIR) reported Q4 EPS of ($0.76), $0.41 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $49.4 million versus the consensus estimate of $149.6 million.

For earnings history and earnings-related data on Vir Biotechnology Inc. (VIR) click here.

... More